Crescent Capital BDC, Inc. (CCAP) - Q1 2020 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2020. Crescent Capital BDC, Inc. is a closed-end, externally managed business development company (BDC) and regulated investment company (RIC). The quarter was significantly impacted by the completion of the Alcentra Capital Corporation acquisition on January 31, 2020, and the onset of the COVID-19 pandemic, which caused significant market volatility and credit spread widening.
Key Financial Metrics
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Total Investment Income | $18.8 million | $11.5 million |
| Net Investment Income | $11.6 million | $6.8 million |
| Net Increase (Decrease) in Net Assets from Operations | $(74.5) million | $8.9 million |
| Net Asset Value (NAV) per Share | $16.52 | $19.50 |
| Total Debt (Carrying Value) | $422.1 million | $322.0 million |
| Weighted Average Interest Rate on Debt | 4.00% | 4.56% |
| Asset Coverage Ratio | 2.08 to 1 | 2.23 to 1 |
| Cash and Cash Equivalents | $3.7 million | $4.6 million |
Material Changes vs. Prior Period
- Significant Net Loss: The Company reported a net decrease in net assets of $74.5 million, compared to a net increase of $8.9 million in Q1 2019. This was primarily driven by a net unrealized depreciation of approximately $82.6 million on investments due to market volatility and credit spread widening associated with the COVID-19 pandemic.
- Alcentra Acquisition: The acquisition of Alcentra Capital Corporation was completed on January 31, 2020. The transaction was accounted for as an asset acquisition, resulting in a realized loss of $3.8 million because the total consideration paid exceeded the fair value of net assets acquired.
- Portfolio Growth: Total investments at fair value increased to $883.2 million from $726.5 million at year-end 2019, largely due to the Alcentra portfolio addition ($195.7 million at cost).
- Expense Increases: Total expenses rose to $10.1 million from $6.6 million, driven by higher interest costs due to increased leverage and the Alcentra acquisition. However, the Advisor waived $1.2 million in management fees and $1.9 million in incentive fees.
- Non-Accrual Status: The number of portfolio companies on non-accrual status increased from one (Q4 2019) to four (Q1 2020), representing 3.4% of total debt investments at cost.
Guidance, Outlook, and Risks
- COVID-19 Impact: Management highlighted the unprecedented impact of the pandemic on liquidity, credit markets, and portfolio valuations. The Company is monitoring covenant compliance and liquidity closely.
- Stock Repurchase Program: The Board terminated the $20 million stock repurchase program on April 9, 2020, to preserve financial flexibility and liquidity.
- Asset Coverage Ratio: Stockholders approved a proposal to reduce the asset coverage ratio requirement from 200% to 150%, effective May 5, 2020, providing greater leverage flexibility.
- Dividends: A regular cash dividend of $0.41 per share was declared for the quarter, payable in July 2020.
- Risks: Key risks include the potential for further unrealized depreciation, liquidity constraints in the credit markets, and the possibility of breaching debt covenants if asset values continue to decline.
Investor Verification Checklist
- Verify the extent of unrealized depreciation in the portfolio, specifically in sectors most impacted by the pandemic (e.g., consumer services, energy).
- Review the details of the Alcentra Acquisition integration and the $3.8 million realized loss impact on future earnings.
- Monitor the Company's compliance with debt covenants and the utilization of its $156.5 million in undrawn credit facility capacity.
- Assess the impact of the terminated stock repurchase program on future share count and NAV per share.
- Confirm the status of the four portfolio companies currently on non-accrual status and potential recovery values.